Health ❯ Healthcare

Antibiotic Resistance

Drug-Resistant Infections Bacterial Infections Infection Control Superbugs Treatment Options Microbiome Solutions Concerns Overprescribing Infections Drug Development Beta-Lactam/Beta-Lactamase Inhibitors Infectious Diseases Public Health Crisis Pediatric Health Multidrug-Resistant Pathogens Public Health Threats Phage Therapy Public Health Issues Risk Factors Global Health Threats Treatment Monitoring Infection Management Global Health Issues Vancomycin-resistant Enterococcus Consequences

FDA Approves Utebzi as First Oral Carbapenem for Complicated UTIs

The decision gives adults with limited or no oral options a potential substitute for hospital-based intravenous therapy.

Peer-Reviewed Study Validates Six-Hour Urine Test for Targeted UTI Treatment

Prototype Breath Test Flags Bacterial Infections in Mice Within Minutes

FDA Approves Two First-in-Class Oral Treatments for Gonorrhea